Assistant Professor of Medicine, Cardiovascular Division, Department of Medicine, Washington University School of Medicine
Clinical Cardiac Electrophysiologist, Barnes-Jewish Hospital, Saint Louis, MO
Clinical Cardiac Electrophysiologist, Parkland Hospital, Farmington, MO
Member of the Cardiac Bioelectricity and Arrhythmia Center (CBAC), Washington University in Saint Louis
Washington University School of Medicine
Saint Louis, MO 63110
Education and Training:
2005-2009 Fellow, Cardiovascular Diseases and Electrophysiology, Barnes-Jewish Hospital, Washington University in Saint Louis
2004—2005 Chief Resident, Internal Medicine, Northwestern University, Chicago, IL
2001-2004 Residency, Internal Medicine, Northwestern University, Chicago, IL. Alpha Omega Alpha
1997-2001 Doctor of Medicine, Vanderbilt University School of Medicine, Nashville, TN
1993-1997 Bachelor of Science, Biochemistry, Boston College, Chestnut Hill, MA. Summa Cum Laude
Clinical Expertise:
Arrhythmias, sudden cardiac death, atrial fibrillation, ventricular tachycardia, inherited (genetic) disorders of the heart. I see patients in the hospital and in clinic for consultation regarding heart rhythm disorders. Additionally, I attend in the Cardiac Care Unit (CCU) at Barnes-Jewish Hospital.
Research interests:
Electrocardiographic Imaging (ECGI): In collaboration with Dr. Yoram Rudy (Washington University Biomedical Engineering), we have applied a new noninvasive imaging system (ECGI) to create three-dimensional maps of arrhythmias, with a focus on ventricular tachycardia (VT) and atrial fibrillation (AF). Through better understanding of basic mechanisms of arrhythmia, the ultimate clinical application of this research is to tailor specific therapies for individual patients based on the unique characteristics of each arrhythmia.
HYBRID-AF Procedure: In collaboration with Drs. Ralph Damiano and Hersh Maniar (Washington University Cardiothoracic Surgery), we have developed a novel procedure to treat symptomatic medicine-refractory AF. The new procedure simultaneously combines a thoracoscopic approach to the epicardium and percutaneous access to the endocardium to provide more durable ablation lesions to treat AF. The ultimate goal is to develop a procedure that replicates the long-term success of the Cox-Maze procedure with the safety profile of a catheter ablation procedure.
Risks and Benefits of Implantable Defibrillators (ICDs): In collaboration with colleagues in the Cardiac Electrophysiology group, we have been able to track long-term outcomes of our patients who underwent implantation of an ICD for the primary prevention of sudden cardiac death over the last eight years. Through a better identification of the patterns of survival and ICD therapy over time, we can help shape future indications for ICD therapy to target patients most likely to receive benefit.
Cardiogenetic Syndromes: In collaboration with specialists from St. Louis Children’s Hospital, Washington University cardiac electrophysiology, heart failure, hypertrophic cardiomyopathy and Washington University Genomics and Pathology Services (GPS), we have begun a clinic to address the complex testing, interpretation and counseling for patients and families with suspected genetic syndromes that affect the heart. Current efforts focus on diseases such as long QT syndrome (LQTS), arrhythmogenic right ventricular cardiomyopathy (ARVC), hypertrophic cardiomyopathy (HCM), catecholaminergic polymporhic ventricular tachycardia (CPVT), Brugada syndrome (BrS), and dilated cardiomyopathies with conduction system disease.
Publications: 